<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: There have been several previous studies showing that <z:chebi fb="0" ids="4031">ciclosporin</z:chebi>, a ligand for cyclophilin D (CypD), reduces <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> permeability transition (mPT) and ameliorates delayed neuronal <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>NIM811 is a non-immunosuppressive <z:chebi fb="0" ids="4031">ciclosporin</z:chebi> derivative that also inhibits mPT, but has significantly less cytotoxicity than <z:chebi fb="0" ids="4031">ciclosporin</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Actually, in animal experiments, several investigators have reported that NIM811 ameliorates central <z:mp ids='MP_0008912'>nervous</z:mp> system disorders, such as traumatic brain injury, transient focal <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> and spinal cord injury </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, we evaluated whether the <z:chebi fb="0" ids="4031">ciclosporin</z:chebi> derivative, NIM811 reduces mPT and ameliorates delayed neuronal <z:hpo ids='HP_0011420'>death</z:hpo> in the hippocampal CA1 sectors in mice when subjected to transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Male C57BL/6 mice were treated with 50 mg/kg <z:chebi fb="0" ids="4031">ciclosporin</z:chebi>, 10, 50 or 100 mg/kg NIM811 or phosphate-buffered saline </plain></SENT>
<SENT sid="5" pm="."><plain>At 30 min post-injection, <z:hpo ids='HP_0000001'>all</z:hpo> mice were subjected to 20 min bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> (BCCAO) </plain></SENT>
<SENT sid="6" pm="."><plain>To estimate delayed neuronal <z:hpo ids='HP_0011420'>death</z:hpo>, the sections were prepared for HE staining and terminal deoxynucleotidyl transferase-mediated <z:chebi fb="0" ids="17625">dUTP</z:chebi> end-labelling (TUNEL) staining at 72 h after 20 min BCCAO </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, using <z:chebi fb="0" ids="52862">5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine</z:chebi> <z:chebi fb="1" ids="16382">iodide</z:chebi> (<z:chebi fb="0" ids="52097">JC-1</z:chebi>) staining technique, we evaluated whether NIM811 (1, 10, 100 or 1000 microm) inhibited mPT in the neurons exposed to 100 microm <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Both delayed neuronal injury and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the hippocampal CA1 sectors were significantly ameliorated at 72 h after transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> in the mice treated with 100 mg/kg NIM811 or 50 mg/kg <z:chebi fb="0" ids="4031">ciclosporin</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>The treatments with 100 microm and 1,000 microm NIM811 significantly inhibited the reduction of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane potential in the neurons exposed to 100 microm <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: These findings strongly suggest that NIM811 inhibits mPT and ameliorates delayed neuronal <z:hpo ids='HP_0011420'>death</z:hpo> in mice subjected to transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> </plain></SENT>
</text></document>